NDS expands operations, appoints Murphy as president, CEO

TriMed Staff | | Health Imaging | Artificial Intelligence
NDS Surgical Imaging, a provider of digital technologies for surgical suites, has appointed John Murphy as president and CEO, and expanded operations internationally and in the United States to facilitate operations growth.

The company said Murphy has an executive management background, including the role of president and CEO at Celerity; corporate executive vice president and chief operating officer at PerkinElmer, a role focusing on the PerkinElmer Life and Analytical Sciences strategic business unit, as well as several years as president of PerkinElmer Optoelectronics, and vice president and general management roles at Honeywell International.

The growth for 2007 and 2008 includes European operation expansion and the establishment of a wholly owned subsidiary in Tokyo to serve Asia-Pacific customers, according to the San Jose, Calif.-based NDS. NDS said it has continued to enhance new products, while embarking on a lean manufacturing journey to established operations via a Lean/Six Sigma initiative at its new facility and California headquarters.

TriMed Staff

Related Content

Mayo Clinic and Microsoft partner to advance generative AI in radiology
ACR partners to create AI foundational model assessment website
Could synthetic images replace the need for contrast?
Experts developing AI model that learns from calcium-scoring CT scans
FDA has approved over 1,000 clinical AI applications, with most aimed at radiology
Commercially available AI increases breast cancer detection by nearly 20%

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.